Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares WHO classification of haematolymphoid tumours, fifth edition: lymphoid neoplasms, R-CHOP (lymphoma chemoimmunotherapy), Autologous stem cell transplant (high-dose therapy), CD20 and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: lymphoid neoplasms, Rituximab, Non-Hodgkin lymphoma (all types), IMRT / IGRT (modern external beam) and the tag subtype-page.
Shares Lisocabtagene maraleucel, CD20, CD19, Rituximab and the tag subtype-page.
Shares Nivolumab, PD-1, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
Shares PD-L1, PD-1, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
Shares Autologous stem cell transplant (ASCT), Autologous stem cell transplant (high-dose therapy), Cyclophosphamide and the tag subtype-page.
Shares Doxorubicin, Nivolumab, IMRT / IGRT (modern external beam), Immune checkpoint inhibitors and the tag subtype-page.
Shares Nivolumab, PD-1, Pembrolizumab, Immune checkpoint inhibitors and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.